Nuvilex, Inc. Reports that Phase 2 Microplot Trials of Oraphyte Confirm it To Be a Commercially Viable All-Natural Nematocide

Nuvilex, Inc. Reports that Phase 2 Microplot Trials of Oraphyte Confirm it To
Be a Commercially Viable All-Natural Nematocide

CHERRY HILL, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC
Bulletin Board: NVLX) announced today that it has received the final report
from its Phase 2 microplot trials investigating the use of Oraphyte(TM) as an
all-natural, eco-friendly nematocide for the turfgrass market with results
supporting the commercial viability of the product. Over the past three
years, nematologist and plant pathologist Edward McGawley, Ph.D. of the
Louisiana State University's Agricultural Center (LSU AgCenter) has
investigated the use of Oraphyte(TM) on several species of turfgrass,
including St. Augustine turfgrass (Stenotaphrum secundatum), bermudagrass
(Cynodon dactylon), and creeping bentgrass (Agrostis).

During the summer of 2009, Dr. McGawley and his team of researchers applied
Oraphyte(TM) to the soil of microplots that contained bermudagrass and
creeping bentgrass. The primary goals of the Phase 2 microplot trials were to
determine if Oraphyte(TM) could substantially reduce the populations of six
nematode genera while causing minimal damage to the blades and root structures
of turfgrass. Results from the Phase 2 microplot trials indicate that one
treatment of 7% Oraphyte(TM) is able to reduce the nematode population while
causing little or no damage to the blades and root structures of turfgrass.
Further turf studies with Oraphyte(TM) are underway in a recreational golf
environment.

"With these results in hand, we are able to work toward finalizing our ongoing
discussions with a Fortune 100 company, as well as other private companies
operating in the pesticide industry that have expressed an interest in
licensing the Oraphyte(TM) product for other crop-related uses," stated Martin
Schmieg, Chairman and Chief Executive Officer of Nuvilex, Inc. "Our objective
is to establish a long-term licensing agreement for the marketing and sale of
Oraphyte(TM), and with every favorable test result we receive, we move closer
to making this goal a reality."

About Oraphyte(TM)

Oraphyte(TM) is a biodegradable nematocide for turfgrass and high-value crops
that is derived from plants and other naturally occurring substances.
Oraphyte(TM) can be formulated as a liquid or solid and is composed of orange
terpene oil, Valencia orange oil, hydrogen peroxide, sorbitan monooleate, and
distilled water. All of Oraphyte(TM)'s ingredients are listed on the Office of
Prevention, Pesticides, and Toxic Substances (OPPTS) of the EPA's inert
ingredient list. Such a designation indicates that these ingredients pose
minimal risk to the environment.

From 2007 to 2009, Oraphyte(TM) has undergone testing at LSU, Auburn
University, the University of Florida, Ohio State University, and the United
States Department of Agriculture (USDA) to determine its efficacy and
usefulness as a non-toxic, low-cost alternative to many traditional
nematocides, including Nemacur, Curfew, Telone II, and Temik. In addition to
turfgrass, Oraphyte(TM) has been tested on several high value crops, including
cantaloupes, tomatoes, and cucumbers.

About Nuvilex, Inc.

Nuvilex, Inc. is an emerging healthcare consumer products company. The
Company's lead products include: Last Shot Hangover Remedy(TM), a unique
sugar-free, calorie-free and caffeine-free liquid formula designed to ease the
symptoms of a hangover; Cinnergen(TM), which promotes a healthy glucose
metabolism; Cinnechol(TM), designed to help maintain normal cholesterol levels
and support normal cardiovascular function; and Infinitink®, a permanent yet
more easily removable tattoo ink. The Company's complete portfolio spans
aesthetics, dermatology, environmental and nutraceutical products, all of
which are designed to directly or indirectly improve human health. In March
2009, Nuvilex merged with Freedom2 Holdings, Inc., the developer of
Infinitink®. In conjunction with the merger, the Company changed its name to
Nuvilex, Inc. from eFoodSafety.com. Please visit www.nuvilex.com for
additional information on the Company.

Safe Harbor Statement

Statements contained in this press release that are not strictly historical
are "forward-looking" statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities and Exchange Act of
1934. The forward-looking statements are made based on information available
as of the date hereof, and the Company assumes no obligation to update such
forward-looking statements. Forward-looking statements are sometimes
identified by words such as "intends", "anticipates", "believes", "expects",
and "hopes" and involve a number of risks and uncertainties that could cause
the Company's actual results to differ materially from projected results. All
parties are cautioned that such forward-looking statements involve risks and
uncertainties that could cause the Company's actual results to differ
materially from those in these forward-looking statements. Such risks and
uncertainties include but are not limited to demand for the Company's products
and services, the Company's ability to secure additional financing, and other
factors that may be more fully described in reports to shareholders and
periodic filings with the Securities and Exchange Commission.

Company Contact:

Blair Barnes
Senior Vice President and Chief Financial Officer
Nuvilex, Inc.
Ph: 856-433-6088
Email: bbarnes@nuvilex.com

Press Contact:

Pat Arcand
Arcand & Madison
Ph: 617-576-7777
Email: pat@am-pr.com

SOURCE Nuvilex, Inc.

Company, Blair Barnes, Senior Vice President and Chief Financial Officer of
Nuvilex, Inc., +1-856-433-6088, bbarnes@nuvilex.com; or Press, Pat Arcand of
Arcand & Madison for Nuvilex, Inc., +1-617-576-7777, pat@am-pr.com